Skip to content
Screener

Harrow HROW Operating Income

Operating Income at other companies

AbbVie logo
AbbVieABBV
$6.43B+31.4%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$2.41M+614%
Bausch + Lomb logo
Bausch + LombBLCO
$83M+855%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$93.34M-46.0%
Opko Health logo
Opko HealthOPK
-$6.97M+88.4%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$950M-444%

Segments

By segment

See full
Imprimis Rx$15.12M-52.6%
Branded-$11.63M-278%
Compounding$343K-93.1%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line item2026 / For the Three Months Ended March 31,2025 / For the Three Months Ended March 31,
Selling, general and administrative43,230,00040,513,000
Research and development5,895,0003,026,000
Total operating expenses49,125,00043,539,000
Loss from operations(22,080,000)(11,232,000)
Interest expense, net(5,497,000)(6,548,000)
Loss before income taxes(27,577,000)(17,780,000)
Income tax expense(25,000)-
Net loss$(27,602,000)$(17,780,000)

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's operating income?
Harrow (HROW) reported operating income of -$22.08M in Q1 2026.
How has Harrow's operating income changed year-over-year?
Harrow's operating income decreased by 96.6% year-over-year, from -$11.23M to -$22.08M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Harrow's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude